Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000824515 | SCV000965415 | uncertain significance | Fanconi anemia | 2024-10-23 | criteria provided, single submitter | clinical testing | This variant, c.764_766del, results in the deletion of 1 amino acid(s) of the FANCA protein (p.Arg255del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs555210441, gnomAD 0.02%). This variant has been observed in individual(s) with Fanconi anemia (PMID: 9371798). ClinVar contains an entry for this variant (Variation ID: 134292). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV000824515 | SCV002535073 | uncertain significance | Fanconi anemia | 2022-01-26 | criteria provided, single submitter | curation | |
Revvity Omics, |
RCV001274649 | SCV003833898 | uncertain significance | Fanconi anemia complementation group A | 2019-05-31 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003477513 | SCV004218642 | uncertain significance | not provided | 2024-10-18 | criteria provided, single submitter | clinical testing | The FANCA c.764_766del (p.Arg255del) variant has been reported in the published literature in individual(s) with Fanconi anemia (PMID: 9371798 (1997)) as well as in reportedly healthy individuals (PMID: 24728327 (2014), 29641532 (2018)). The frequency of this variant in the general population, 0.00028 (7/24964 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Based on the available information, we are unable to determine the clinical significance of this variant. |
Mayo Clinic Laboratories, |
RCV003477513 | SCV004224296 | uncertain significance | not provided | 2022-09-13 | criteria provided, single submitter | clinical testing | PM4 |
ITMI | RCV000120965 | SCV000085133 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Natera, |
RCV001274649 | SCV001459003 | uncertain significance | Fanconi anemia complementation group A | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004742268 | SCV005341288 | uncertain significance | FANCA-related disorder | 2024-07-17 | no assertion criteria provided | clinical testing | The FANCA c.764_766delGAA variant is predicted to result in an in-frame deletion (p.Arg255del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.028% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |